Miles C. Miller

RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease

John E. Donahue, Stephanie Flaherty, Conrad E. Johanson et al. · Acta Neuropathologica · 2006 · 494 citations

Neurodegenerative Diseases, Alzheimer's Disease, Neurochemical Biomarkers +5

Amyloid Efflux Transporter Expression at the Blood-Brain Barrier Declines in Normal Aging

Gerald D. Silverberg, Arthur A. Messier, Miles C. Miller et al. · Journal of Neuropathology & Experimental Neurology · 2010 · 185 citations · Full text

Aging, Neurochemical Biomarkers, Alzheimer's Disease +21

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits

Nicholas J. Izzo, Agnes Staniszewski, Lillian K. To et al. · PLoS ONE · 2014 · 185 citations · Full text

Synthetic Abeta Oligomers, Synaptic Signaling, Alzheimer's Disease +18

Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease

Miles C. Miller, Rosemarie Tavares, Conrad E. Johanson et al. · Brain Research · 2008 · 184 citations · Full text

Alzheimer's Disease, Hippocampal Rage Immunoreactivity, Dementia +4

Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent

Crissey L. Pascale, Miles C. Miller, Catherine Chiu et al. · Fluids and Barriers of the CNS · 2011 · 125 citations · Full text